Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 261 publications
Current treatments, practical management, and emerging investigational therapies for myelofibrosis.
Journal: Expert review of hematology
Published: December 14, 2025
Determination of 13 janus kinase inhibitors in anti-alopecia cosmetics by ultra-high performance liquid chromatography-tandem triple quadrupole composite linear ion trap mass spectrometry
Journal: Se pu = Chinese journal of chromatography
Published: September 24, 2025
Canine Mdr1 Knockout MDCK Cells Reliably Estimate Human Small Intestinal Permeability (Peff) and Fraction Absorbed (fa).
Journal: Molecular pharmaceutics
Published: September 07, 2025
Validated LC-MS/MS Method for the Quantitative Determination and Pharmacokinetic Profiling of Fedratinib (TG101348), an Oral JAK2 Inhibitor, in CD1 Mice Plasma.
Journal: Biomedical chromatography : BMC
Published: September 04, 2025
Structural insights into substrate binding of SLC19A3: Comparing inward-open and outward-open conformations.
Journal: International journal of biological macromolecules
Published: August 13, 2025
Discovery of Highly Selective and Potent Macrocyclic JAK2 Inhibitors for the Treatment of MPNs.
Journal: Journal of medicinal chemistry
Published: August 06, 2025
Janus Kinase Inhibitors During Pregnancy and Adverse Drug Reactions: A Pharmacovigilance Disproportionality Analysis in VigiBase.
Journal: Clinical and translational science
Published: August 05, 2025
Cutaneous Extramedullary Hematopoiesis in a Patient With Myelofibrosis.
Journal: American journal of hematology
Published: July 13, 2025
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; nivolumab plus ipilimumab for hepatocellular carcinoma, fedratinib for myelofibrosis, talquetamab for multiple myeloma, and belzutifan for tumors associated with von Hippel-Lindau disease and renal cell carcinoma.
Journal: International journal of clinical oncology
Published: July 11, 2025
JAK inhibitor selection in challenging scenarios of myelofibrosis: a review.
Journal: Haematologica
Published: July 09, 2025
Validated green ultra-fast UPLC-MS/MS method for the quantification of fedratinib in an HLM matrix: application to in vitro and in silico metabolic stability studies.
Journal: Analytical methods : advancing methods and applications
Published: July 01, 2025
Efficacy and Safety of Momelotinib in Myelofibrosis: A Systematic Review and Meta-Analysis With a Focus on Anemia Outcomes.
Journal: Journal of hematology
Published: June 25, 2025
Last Updated: 01/07/2026